Affiliation:
1. Orenburg State Medical University
Abstract
The article presents current information on the pathogenetic role of lipid metabolism disorders and the value of lipotoxicity in renal pathology, contributing to the progression of nephropathy. The detected increase in cholesterol level, TAG, LDL, decrease in plasma HDL concentration in chronic kidney disease (CKD) is accompanied by significant changes in the composition of various lipoproteins caused by changes in the expression and activity of key proteins and enzymes involved in the biosynthesis, transport, remodeling and catabolism of lipids and lipoproteins. It has been proven that dyslipidemia in CKD affects the morphological and functional state of the kidneys, contributing to the development of renal lipotoxicity processes, affecting the structural and functional state of the kidneys, initiating oxidative stress, systemic inflammation, vascular damage, and dysregulation. To date, research on the significance of dyslipidemia as a pathogenetic factor in the formation of chronic kidney disease remains insufficiently studied. Dysregulation of lipid metabolism, leading to dyslipidemia, is often an undervalued complication of CKD.
Publisher
Non-profit organization Nephrology
Reference38 articles.
1. Smirnov AV, Shilov EM, Dobronravov VA et al. National guidelines. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. Nephrology (Saint-Petersburg) 2012;16(1):89–11. (In Russ.) doi: 10.24884/1561-6274-2012-16-1-89-115
2. Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) Guideline Update for Chronic Kidney Disease: Evolution not Revolution. Clinical Chemistry 2013;59(3):462–465. doi: 10.1373/clinchem.2012.184259
3. Agrawal S, Zaritsky JJ, Fornoni A. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 2018;14(1):57–70. doi: 10.1038/nrneph.2017.155
4. Vyalkova AA, Nikolaev SN, Ushakova YuV et al. On the issue of early diagnosis of diabetic nephropathy in children. Nephrology and dialysis 2010;2:124–130 (In Russ.)
5. Vyalkova AA, Lebedeva EN, Krasikov SI et al. Clinical and pathogenetic aspects of kidney damage in obesity (review of literature). Nephrology (Saint-Petersburg) 2014;18(3):24–33 (In Russ.)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献